Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wulingsan Granules in Metabolic Syndrome
NCT04812236Phase 4Unknown
- Sponsor
- Jiangsu Famous Medical Technology
- Start
- Apr 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of oreongsan in metabolic syndrome, sponsored by Jiangsu Famous Medical Technology. Status: unknown.
02
Drugs
oreongsan
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT04812236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04812236.